UPC Stock Analysis: Buy, Sell, or Hold?
UPC - Universe Pharmaceuticals Inc. Ordinary Shares
$2.75
0.02 (0.73%)
▲
5d:
+17.52%
30d:
+4.17%
90d:
-27.82%
BUY
HIGH Confidence
Analysis Updated: Apr 1, 2026 12:00 AM ET
Earnings: Apr 22, 2026
19d
Get Alerted When UPC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: UPC shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
✅ BUY SIGNAL: UPC shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
In-depth Analysis How we analyze
Valuation Analysis: UPC is currently trading at $2.75, which is considered slightly high relative to its 30-day fair value range of $2.42 to $2.81.
Technical Outlook: Technically, UPC is in a downtrend. Immediate support is located at $2.08, while resistance sits at $3.28.
Market Sentiment: UPC has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, UPC is in a downtrend. Immediate support is located at $2.08, while resistance sits at $3.28.
Market Sentiment: UPC has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Fair Price Range
$2.42 -
$2.81
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
76.5%
All Signals
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
Fair Price Analysis
30-Day Fair Range
$2.42 -
$2.81
Current vs Fair Value
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$2.08
Resistance Level
$3.28
Current Trend
Downtrend
Technical data as of
Apr 1, 2026
Fundamental Context
Revenue Growth (YoY)
-14.1%
Earnings Growth (YoY)
-82.0%
Profit Margin
-20.6%
Share & Embed Analysis
Last updated: April 02, 2026 10:46 AM ET
Data refreshes hourly during market hours. Next update: 11:46 AM
Data refreshes hourly during market hours. Next update: 11:46 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is UPC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$178 | 65 BUY |
|
ZTS
Zoetis Inc |
STRONG BUY
19 analysts |
$151 | 57 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$91 | 58 HOLD |
|
HCM
HUTCHMED DRC |
STRONG BUY
14 analysts |
$21 | 65 BUY |
|
TEVA
Teva Pharma Industries L… |
STRONG BUY
11 analysts |
$38 | 64 BUY |
